CytomX Therapeutics, Inc. (FRA:6C1)
Germany · Delayed Price · Currency is EUR 3.444
-0.130 (-3.64%)
Last updated: Jan 6, 2026, 8:03 AM CET
282.88% (1Y)
| Market Cap | 633.64M |
| Revenue (ttm) | 96.85M |
| Net Income (ttm) | 23.88M |
| Shares Out | n/a |
| EPS (ttm) | 0.20 |
| PE Ratio | 26.53 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 259 |
| Open | 3.444 |
| Previous Close | 3.574 |
| Day's Range | 3.444 - 3.444 |
| 52-Week Range | 0.384 - 3.822 |
| Beta | n/a |
| RSI | 56.69 |
| Earnings Date | Mar 6, 2026 |